Tranexamic acid 1000 mg from Japan (bleeding, fibrinolysis)
What are Tranexamic acid injections 1000 mg?
Tranexamic acid in injections by Nissin Pharmaceuticals passed all required clinical trials and was launched at Japanese market in 2008 under the permit number 22600AMX00894000.
It is used extensively in Japan for abnormal hemorrhages. Tranexamic acid has shown to be effective in fibrinolysis (leukemia and aplastic anemia), as well as abnormal hemorrhages during or after surgery. The injections are particularly used with local fibrinolysis (pulmonary, nasal, and genital hemorrhages), renal hemorrhage or abnormal hemorrhage after or during surgery on the prostate gland.
Tranexamic acid injections are also widely used in cosmetology for promoting skin whitening. This medicine helps to remove pigment spots, including age-related spots and freckles, to even the complexion and to whiten the skin, working especially effectively for the darker skin tones.
Active principles: tranexamic acid
Amount: 50 ampoules
Maker: Nissin Pharmaceutical Co., Ltd., Tendo, Yamagata, Japan
- treatment of bleeding
- treatment of the effects of blood loss due to local and general fibrinolysis,
- skin whitening.
How to take
This medicine should be used one or twice a day according to the prescription of your doctor. In general, the dosages ranges between 250-500 mg a day for normal cases and 500-1000 mg a day during surgeries.
Contraindications: do not use for children, pregnant or breastfeeding women, patients with thrombus (cerebral thrombosis, myocardial infarction, thrombophlebitis, etc.), consumptive coagulopathy and renal failure, patients at risk of thrombosis or postoperative immobile patients.
If an allergic reaction occurs, patient needs to stop using the medicine and consult with their doctor. If patient is taking any other medication or treatment, they should consult with their doctor in advance.